Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.0020
+0.0004 (25.00%)
At close: Nov 11, 2026
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $2.49 thousand as of November 13, 2026. It is the 52,284th most valuable company in the world and the 8,226th biggest in the United States. Its market cap has decreased by 90.48% in one year.
Market Cap
2.49K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,226 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 2.49K, a decrease of -99.99%. That is a compound annual growth rate of -80.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 2.49K | -81.98% |
| Dec 31, 2025 | 13.79K | -99.55% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
| Feb 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| eFFECTOR Therapeutics | 3.76K |
| Synovics Pharmaceuticals | 3.65K |
| Innoveren Scientific | 3.20K |
| Hemagen Diagnostics | 3.10K |
| Comera Life Sciences Holdings | 3.07K |
| Lipella Pharmaceuticals | 2.77K |
| Syros Pharmaceuticals | 2.68K |
| Anthera Pharmaceuticals | 2.62K |